300573 兴齐眼药
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)9.91638.97020.59414.80714.615
总资产报酬率 ROA (%)7.80729.82316.28612.61112.202
投入资产回报率 ROIC (%)9.53235.92918.84814.35713.973

边际利润分析
销售毛利率 (%)82.05281.15778.33177.37378.744
营业利润率 (%)34.03633.25021.85618.84220.011
息税前利润/营业总收入 (%)33.57032.53420.37717.63218.052
净利润/营业总收入 (%)30.20728.14017.39516.35616.937

收益指标分析
经营活动净收益/利润总额(%)98.361100.638101.116101.219100.820
价值变动净收益/利润总额(%)0.0000.000-0.0060.0000.000
营业外收支净额/利润总额(%)-1.068-2.742-7.523-4.350-7.010

偿债能力分析
流动比率 (X)2.2341.8581.7983.4805.675
速动比率 (X)1.8091.4811.4662.9574.873
资产负债率 (%)20.51022.09325.12116.49912.936
带息债务/全部投入资本 (%)1.2041.1508.0330.670-3.978
股东权益/带息债务 (%)7,998.1878,342.0471,094.71614,211.811-2,488.692
股东权益/负债合计 (%)387.557352.637298.081506.080673.062
利息保障倍数 (X)-316.730189.429406.238-41.567-27.885

营运能力分析
应收账款周转天数 (天)35.30436.72838.82136.97833.425
存货周转天数 (天)148.490132.432123.797140.014145.398